Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination.

Ther Adv Gastroenterol · 2023 · PMC10350576 · PMID 37461738

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Anti-SARS-CoV-2 S antibody titers in patients showed a decreasing trend in the following order of treatment: AZA, HC, BT, and combined biologic and immunosuppressive therapy (mean values of mRNA vaccination subgroup: NONE group: 8179 U/mL, AZA group: 4880 U/mL, HC group: 1931 U/mL, BT group: 1861 U/mL, COMB: 1624.5 U/mL; p < 0.001).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.